FDA Drug Application (019011) for GOLYTELY by BRAINTREE

Back to FDA Applications sponsored by BRAINTREE

Application Number019011
Product Number001
FormFOR SOLUTION;ORAL
Dosage236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AA Products in conventional dosage forms not presenting bioequivalence problems
Reference Drug
Drug NameGOLYTELY
Active IngredientPOLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS

Active IngredientCount
List of drugs with Active Ingredient POLYETHYLENE GLYCOL 335028
List of drugs with Active Ingredient POTASSIUM CHLORIDE279
List of drugs with Active Ingredient SODIUM BICARBONATE53
List of drugs with Active Ingredient SODIUM CHLORIDE352
List of drugs with Active Ingredient SODIUM SULFATE ANHYDROUS12


Back to FDA Applications sponsored by BRAINTREE